An interventional study of Hand training (Physiotherapy) for Group A and Hand training (Physiotherapy) for Group B. in Myotonic Dystrophy, sponsored by University of Pecs. Completed at 1 site in Hungary. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by University of Pecs · Not applicable, Interventional, and Other
Physiotherapy is essential for patients suffering from chronic muscle diseases or nerve damage. These conditions often reduce hand strength and dexterity, which significantly impacts daily quality of life. Since travelling to in-person therapy can be difficult due to mobility issues, this project provides a home-based, small-group hand training program guided live by a physiotherapist via an online video platform (such as Google Meet).
The study uses a cross-over design. After initial assessments, patients are randomly split into two groups that take turns participating in a 12-week exercise program. The online sessions take place three times a week for one hour, with patients sitting at a table at home. The physiotherapist is present online to provide real-time feedback and interact with the participants.
In-person health assessments are conducted at the Department of Neurology, University of Pécs. These check-ups take place at the very beginning, right before and after the 12-week training period, and during a 3-month follow-up. The tests measure hand dexterity and walking ability, while questionnaires evaluate daily hand use, activities of daily living, fatigue, and mood.
Introduction The importance of rehabilitation and physiotherapy for patients suffering from muscle diseases and neuropathy has already been highlighted by numerous studies. Since many patients live far from specialized centers and face mobility constraints, attending center-based, in-person physiotherapy sessions is highly challenging. Social isolation and the fear of falling further hinder participation in exercise programs.
Telerehabilitation dates back a few decades, but its implementation via videoconferencing platforms (e.g., Zoom, Skype, Google Meet, Teams, etc.) has begun to expand rapidly since the COVID-19 pandemic, approximately 3-4 years ago, when these platforms became widely adopted across schools and workplaces. Today, the widespread availability of smartphones and other computing devices in Hungary allows patients living far from specialized centers to join physiotherapy sessions remotely through these channels.
Due to the novelty of this method, examples and protocols are scarce and remain to be developed. Ensuring safety and preventing or, if necessary, managing falls and injuries is of paramount importance during physiotherapy. Therefore, when introducing this method, an area was selected where the likelihood of such incidents is minimal: hand exercises, which patients can perform while seated. At the same time, weakness in the distal hand muscles can be a severely limiting factor in daily life; thus, improving hand dexterity can lead to an enhanced quality of life.
The benefit of small-group sessions (5-7 patients per group) may include a reduction in social isolation, and a supportive environment could encourage the integration of more physical activity into daily life. (This was also observed during a previous study involving a 3-week treatment program in a rehabilitation hospital with small patient groups). Consequently, rest periods during the videoconference sessions will be utilized to incorporate opportunities for conversation, social connection, health education, and motivation for physical activity. Furthermore, alongside hand function assessments, tests evaluating quality of life, fatigue, and daily functioning have been integrated into the evaluation battery.
In the first phase of the planned study, the intention is to invite 12-14 patients managed in Pécs, primarily those suffering from myotonic dystrophy type 1 (DM1). The objective of this phase is to test and fine-tune the method. Plans are in place to expand the scope of the study based on these initial experiences.
Study Objectives Primary objective To improve the hand function and manual dexterity of participating patients, thereby enhancing participation in daily life and overall quality of life.
Secondary objectives
The assessments required for the study (baseline, interim, and post-intervention data collection, as well as data processing) will take place at the Department of Neurology, Clinical Center, University of Pécs. The manipulation-developing hand training will be conducted via videoconferencing (e.g., Google Meet or Zoom), with patients participating in these sessions by logging in from home.
Following the provision of patient information and the signing of the informed consent form, baseline assessments in Pécs will include verifying whether patients can effectively use the videoconferencing platform. Baseline clinical assessments (detailed below) will then be performed, comprising motion evaluations (e.g., the 9-Hole Peg Test) in addition to questionnaires. Next, patients will be randomly allocated into two groups. After the first group completes the 12-week videoconference-assisted physiotherapy program, assessments will be repeated in Pécs. This will be followed by the 12-week physiotherapy program for the second group (planned with a 2-to-6-week delay), which will also be followed by post-intervention assessments (crossover study design). During the intervention and the weeks following it, patients will be asked to maintain a simple physical activity diary (for 2x2 weeks).
The first phase of the study is scheduled to begin in the spring of 2024. The group physiotherapy will last for 12 weeks, encompassing two or three sessions per week, with a duration of 45-60 minutes per session.
During the assessments, hand muscle strength (MRC scale, grip force, and pinch force), hand and arm dexterity (9HPT, Box and Blocks test), and walking ability (6/2-minute walk test) will be evaluated. Self-administered (and to a small extent, investigator-administered) questionnaires will be used to assess hand dexterity and hand use (DASH, Cochin, ACTIVLIM, ABILHAND), subjective balance confidence and fear of falling (FES-I, ABC), quality of life (SF-36, INQoL), mood and perception of fatigue (Beck Depression Inventory, FSS), as well as DM1-specific scales (MIRS, DM1 Disability Scale, and DM1-Active).
Each physiotherapy session will last 60 minutes. Following a brief opening circle, the plan is to conduct 2-3 blocks of 10-15 minutes of guided hand training, primarily utilizing therapeutic putty with resistance levels tailored to muscle strength, alongside other simple tools (e.g., pencils, ping-pong balls). During the breaks, brief informational segments aimed at health education and encouraging physical activity will be provided, and feedback will be requested regarding recent experiences and perceptions related to exercise.
Methodology and Study Organization The study is open-label, non-invasive, prospective, and features a crossover design. The methods and procedures directly involving patients do not exceed the scope of routine, protocol-based clinical care.
The "9-Hole Peg Test" and a hand function assessment scale (DASH or Cochin) have been selected as primary endpoints; all other assessments will be considered secondary endpoints.
126 studies on the registry are indexed under Myotonic Dystrophy; 50 are open to participants now.
This study's enrollment of 14 is below the median of 40 across 67 interventional studies indexed under Myotonic Dystrophy.
Browse Myotonic Dystrophy studies →University of Pecs is the lead sponsor of 106 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
For Group A: Intervention: Hand training (physiotherapy) form Week 0 to Week 12 (60 minute physiotherapy sessions 3 times/week). A 24 week wash-out period from Week 12 to 36 Control period from Week 36-48.
Other: Hand training (Physiotherapy) for Group A
For Group B: Intervention: Control period Week 0 to Week 12. Hand training (physiotherapy) form Week 36 to Week 48 (60 minute physiotherapy sessions 3 times/week).
Other: Hand training (Physiotherapy) for Group B.
A 12-week home-based, synchronous hand-training program supervised remotely via interactive video conferencing. The training program focuses on hand dexterity. For Group A, the intervention was between weeks 0-12. Control period was from Week 36-48. For Group B, the intervention was between weeks 36-48.
A 12-week home-based, synchronous hand-training program supervised remotely via interactive video conferencing. The training program focuses on hand dexterity. For Group B, the intervention was between weeks 36-48. Weeks 0-12 served as the control period. Weeks 12-36 was a wash-out period.
9 Hole Peg Test
Nine-Hole Peg Test (9HPT)evaluates fine motor skills and manual dexterity .The test will be administered four times per hand, with the resting periods between active attempts utilized by patients to complete the assigned questionnaires. Results will be recorded as total completion time in seconds.
Time frame: Recorded on weeks 0, 12, 36 and 48.
10x Palm opening test (measurement of hand myotonia).
10x Relaxation Test: Objective hand myotonia will be assessed functionally using the 10-repetition palm-opening test. Patients held their hands in front of them with elbows flexed at 90 degrees and palms facing forward. From the starting position of a maximum clenched fist, they were instructed to fully extend all fingers as rapidly as possible, repeating this sequence for ten consecutive repetitions. Test durations will be recorded in seconds.
Time frame: Recorded for both groups on weeks 0, 12, 36, 48. Interim measurement for group A at weeks 4, 8; for group B at weeks 40 and 44.
Box and Blocks Test (BBT)
Gross manual dexterity will be evaluated using the BBT. The test quantifies the total number of individual wooden blocks successfully transferred one by one over a central partition from one compartment to another within a strict 60-second timeframe. This test was performed once with each upper extremity.
Time frame: Recorded for both groups on weeks 0, 12, 36, 48.
Plan to share: Yes — Data available upon request from the corresponding author.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: From January 2027.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.